Why the study?
Does serum testing for B-type natriuretic peptide (BNP) improve diagnosis and guide therapy in patients with congestive heart failure?
Does serum testing for B-type natriuretic peptide (BNP) improve diagnosis and guide therapy in patients with congestive heart failure?
Answers are grounded in this paper and cite their sources.
Serum BNP measurement may be clinically useful for diagnosing and guiding therapy in patients with congestive heart failure.
Serum testing for the hormone B-type natriuretic peptide (BNP) may have clinical utility in congestive heart failure (CHF). This hormone is secreted predominantly by the left ventricular myocardium in patients with CHF. Measurement of serum BNP may improve diagnosis of CHF and may also help guide therapy in patients with CHF. The literature regarding the clinical utility of BNP measurement in CHF is reviewed.
No takes yet. Share an insight, caveat, or question.
Spevack et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: